Simple test could predict response to anthracycline chemotherapy for patients with 'triple negative' breast cancer

Could this be a turning point in breast cancer research?

Researchers at Queen’s University Belfast have found a new biomarker that could predict the effectiveness of a common type of chemotherapy for patients with triple negative breast cancer. To read more about this exciting discovery, click the link below:

Share This Article